Portia Knowlton

Portia Knowlton

Portia Knowlton is a program coordinator for the St. Jude HPV cancer prevention program.

Medulloblastoma and microirradiation: Tiny treatments for the most common malignant pediatric brain tumor

Medulloblastoma and microirradiation: Tiny treatments for the most common malignant pediatric brain tumor

Posted by Martine F. Roussel, PhD | Feb 18, 2019

Medulloblastoma may soon be treated by a microirradiator - a machine the size of two refrigerators that beams radiation down to half the width of a credit card.

Learn more
Blazing through new territory to fight a devastating neurodegenerative disease

Blazing through new territory to fight a devastating neurodegenerative disease

Posted by St. Jude Communications Department | Jan 17, 2019

Read how researchers have found a path to control coenzyme A and possibly prevent a devastating neurodegenerative disease.

Learn more
Genetic sequencing: How do we put out the fires of genetically driven cancers?

Genetic sequencing: How do we put out the fires of genetically driven cancers?

Posted by Jill Bouchard, PhD | Nov 8, 2019

Too much of a good thing? Read how genetic sequencing offers insights into the causes of some cancers, but the avalance of data creates a new set of issues.

Learn more
Optimizing leukemia treatment through pharmaceutical science

Optimizing leukemia treatment through pharmaceutical science

Posted by Mary Relling, PharmD | Jun 19, 2019

Effective leukemia treatment is one thing – making sure it’s optimized with minimal implications is another. Read research juggles both to help patients.

Learn more
Separating fact from fiction using pharmacogenetics

Separating fact from fiction using pharmacogenetics

Posted by Mary Relling, PharmD | Oct 8, 2019

Improving understanding of drugs and how the body reacts to them - - Read how science is improving understanding of genes and medication.

Learn more
In times of grief, be present to offer comfort and support

In times of sorrow, being present to offer comfort and support often matters more than the right words or actions

Posted by Lisa Clark, PhD | Oct 12, 2017

Being present after the death of a friend or loved one often matters more to those suffering grief than the right words or actions.

Learn more
Supercharging T Cells to Fight Cancer

Supercharging T cells to fight cancer

Posted by Ben Youngblood, PhD | Nov 28, 2017

St. Jude researchers are combining therapeutic methods that induce epigenetic reprogramming with immune checkpoint blockade to enhance cancer treatments.

Learn more
Helping childhood cancer survivors thrive

Helping childhood cancer survivors thrive

Posted by Tim Folse, MD | Sep 18, 2017

Discover how St. Jude is helping cancer survivors manage the long-term effects of treatment and set up screening guidelines for those still in treatment.

Learn more
Uncovering the body’s immune system response

Discovering new molecular switches to control autoinflammatory disease

Posted by Thirumala-Devi Kanneganti, PhD | Aug 4, 2017

Is Ptpn6, a controlling gene, linked with the master immune switch IL-1 alpha? Can this link be mapped to help pinpoint immune system response? Find out more.

Learn more
Apoptosis or necroptosis? The caspase-8 protein decides

Apoptosis or necroptosis? The caspase-8 protein decides

Posted by Douglas R. Green, PhD | Oct 20, 2017

Programmed cell death can affect immune response to diseases such as cancer. Learn how caspase-8 chooses cell death and how that decision can be stopped.

Learn more
Load more posts